Safety really comes down to proper dosing and patient selection by a licensed provider. A 2025 review that assessed the safety profiles of both drugs found that the most common adverse effects are the same for both tirzepatide and semaglutide, namely, nausea, vomiting and diarrhea
In these trials, the medication was started at a very low dose, and the dosage was escalated gradually to maximize efficacy while minimizing early adverse effects, particularly gastrointestinal events that were consistent with Phase 2
26, 2024 (HealthDay News) -- The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm
Semaglutide works steadily and sustainably, helping your body lose weight in a healthy and controlled manner
What is the role of vitamin b12
Managing side effects GLP-1 side effects are the same regardless of where you purchased the medication